Published in J Struct Biol on September 30, 2009
Direct Host Plasminogen Binding to Bacterial Surface M-protein in Pattern D Strains of Streptococcus pyogenes Is Required for Activation by Its Natural Coinherited SK2b Protein. J Biol Chem (2015) 0.82
Dimerization is not a determining factor for functional high affinity human plasminogen binding by the group A streptococcal virulence factor PAM and is mediated by specific residues within the PAM a1a2 domain. J Biol Chem (2014) 0.78
NMR backbone dynamics of VEK-30 bound to the human plasminogen kringle 2 domain. Biophys J (2010) 0.75
Conformationally Organized Lysine Isosteres in Streptococcus Pyogenes M Protein Mediate Direct High-Affinity Binding to Human Plasminogen. J Biol Chem (2017) 0.75
Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28
NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR (1995) 93.94
MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph (1996) 39.73
Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J Biomol NMR (1999) 26.99
WHAT IF: a molecular modeling and drug design program. J Mol Graph (1990) 24.35
The global burden of group A streptococcal diseases. Lancet Infect Dis (2005) 13.58
Using NMRView to visualize and analyze the NMR spectra of macromolecules. Methods Mol Biol (2004) 8.02
Determination of the secondary structures of proteins by circular dichroism and optical rotatory dispersion. Biochemistry (1972) 5.71
Streptococcal M protein: alpha-helical coiled-coil structure and arrangement on the cell surface. Proc Natl Acad Sci U S A (1981) 5.56
Refinement of protein structures in explicit solvent. Proteins (2003) 5.31
A surface protease and the invasive character of plague. Science (1992) 4.44
RECOORD: a recalculated coordinate database of 500+ proteins from the PDB using restraints from the BioMagResBank. Proteins (2005) 3.41
Identification of a specific receptor for plasmin on a group A streptococcus. Infect Immun (1987) 1.72
Identification of a plasminogen-binding motif in PAM, a bacterial surface protein. Mol Microbiol (1995) 1.27
Kringle 2 mediates high affinity binding of plasminogen to an internal sequence in streptococcal surface protein PAM. J Biol Chem (1998) 1.21
The refined structure of the epsilon-aminocaproic acid complex of human plasminogen kringle 4. Biochemistry (1991) 1.11
Structure and binding determinants of the recombinant kringle-2 domain of human plasminogen to an internal peptide from a group A Streptococcal surface protein. J Mol Biol (2001) 1.10
An efficient system for small protein expression and refolding. Biochem Biophys Res Commun (2004) 1.06
Streptococcal M protein: structural studies of the hypervariable region, free and bound to human C4BP. Biochemistry (2006) 1.06
Solution structure and dynamics of the plasminogen kringle 2-AMCHA complex: 3(1)-helix in homologous domains. Biochemistry (1999) 0.99
The cell-binding domains of plasminogen and their function in plasma. J Biol Chem (1988) 0.95
Structure and ligand binding determinants of the recombinant kringle 5 domain of human plasminogen. Biochemistry (1998) 0.92
The X-ray crystallographic structure of the angiogenesis inhibitor angiostatin. J Mol Biol (2002) 0.90
Crystal structures of the recombinant kringle 1 domain of human plasminogen in complexes with the ligands epsilon-aminocaproic acid and trans-4-(aminomethyl)cyclohexane-1-carboxylic Acid. Biochemistry (1996) 0.87
The plasminogen activation system in tumour invasion and metastasis. Pathol Res Pract (1996) 0.86
Solution structure of the tissue-type plasminogen activator kringle 2 domain complexed to 6-aminohexanoic acid an antifibrinolytic drug. J Mol Biol (1991) 0.86
X-ray crystallographic structure of the angiogenesis inhibitor, angiostatin, bound to a peptide from the group A streptococcal surface protein PAM. Biochemistry (2006) 0.85
Amino acid residues of the kringle-4 and kringle-5 domains of human plasminogen that stabilize their interactions with omega-amino acid ligands. J Biol Chem (1994) 0.85
Amino acids of the recombinant kringle 1 domain of human plasminogen that stabilize its interaction with omega-amino acids. Biochemistry (1993) 0.84
An internal histidine residue from the bacterial surface protein, PAM, mediates its binding to the kringle-2 domain of human plasminogen. J Pept Res (2000) 0.83
Enhancement through mutagenesis of the binding of the isolated kringle 2 domain of human plasminogen to omega-amino acid ligands and to an internal sequence of a Streptococcal surface protein. J Biol Chem (1999) 0.83
Construction, expression, and purification of recombinant kringle 1 of human plasminogen and analysis of its interaction with omega-amino acids. Biochemistry (1991) 0.82
Molecular assembly of plasminogen and tissue-type plasminogen activator on an evolving fibrin surface. Eur J Biochem (1993) 0.80
Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C. J Exp Med (2007) 3.35
Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo. Blood (2007) 2.92
Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells. J Clin Invest (2009) 1.86
Tuning the electronic absorption of protein-embedded all-trans-retinal. Science (2012) 1.70
The fibrin-derived peptide Bbeta15-42 protects the myocardium against ischemia-reperfusion injury. Nat Med (2005) 1.66
Plasminogen activator inhibitor-1 (PAI-1) is cardioprotective in mice by maintaining microvascular integrity and cardiac architecture. Blood (2009) 1.59
A missense mutation in the sodium phosphate co-transporter Slc34a1 impairs phosphate homeostasis. J Am Soc Nephrol (2008) 1.51
FXI is essential for thrombus formation following FeCl3-induced injury of the carotid artery in the mouse. Thromb Haemost (2002) 1.49
Deletion of murine kininogen gene 1 (mKng1) causes loss of plasma kininogen and delays thrombosis. Blood (2007) 1.48
Crystal structure of potato tuber ADP-glucose pyrophosphorylase. EMBO J (2005) 1.42
Activated protein C targets CD8+ dendritic cells to reduce the mortality of endotoxemia in mice. J Clin Invest (2010) 1.41
Acute inflammation is exacerbated in mice genetically predisposed to a severe protein C deficiency. Blood (2006) 1.38
ADP-ribosylation factor 6 regulates tumorigenic and invasive properties in vivo. Cancer Res (2009) 1.37
Plasminogen receptors: the sine qua non of cell surface plasminogen activation. Front Biosci (2005) 1.36
The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b. J Clin Invest (2010) 1.36
Retracted Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality. Blood (2009) 1.36
Early platelet dysfunction: an unrecognized role in the acute coagulopathy of trauma. J Am Coll Surg (2012) 1.35
Rapid selection of Drosophila S2 cells with the puromycin resistance gene. Biotechniques (2003) 1.35
A cardioprotective role for the endothelial protein C receptor in lipopolysaccharide-induced endotoxemia in the mouse. Blood (2004) 1.35
Structure and compatibility of a magnesium electrolyte with a sulphur cathode. Nat Commun (2011) 1.30
Iminonitroso Diels-Alder reactions for efficient derivatization and functionalization of complex diene-containing natural products. Org Lett (2007) 1.28
Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse. Physiol Genomics (2003) 1.26
NTP-driven translocation by human RNA polymerase II. J Biol Chem (2003) 1.24
Plasma levels of bradykinin are suppressed in factor XII-deficient mice. Thromb Haemost (2006) 1.21
The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications. Blood (2009) 1.21
A single plasmid transfection that offers a significant advantage associated with puromycin selection in Drosophila Schneider S2 cells expressing heterologous proteins. Cytotechnology (2008) 1.21
The crystal structures of the open and catalytically competent closed conformation of Escherichia coli glycogen synthase. J Biol Chem (2009) 1.18
Mice with a severe deficiency in protein C display prothrombotic and proinflammatory phenotypes and compromised maternal reproductive capabilities. J Clin Invest (2005) 1.17
A protein C deficiency exacerbates inflammatory and hypotensive responses in mice during polymicrobial sepsis in a cecal ligation and puncture model. Am J Pathol (2004) 1.11
Protein design: reengineering cellular retinoic acid binding protein II into a rhodopsin protein mimic. J Am Chem Soc (2007) 1.10
Endothelial protein C receptor-assisted transport of activated protein C across the mouse blood-brain barrier. J Cereb Blood Flow Metab (2008) 1.10
Enhanced in vitro proliferation of aortic endothelial cells from plasminogen activator inhibitor-1-deficient mice. J Biol Chem (2003) 1.08
The X-ray crystallographic structure of Escherichia coli branching enzyme. J Biol Chem (2002) 1.07
A trimeric HIV-1 fusion peptide construct which does not self-associate in aqueous solution and which has 15-fold higher membrane fusion rate. J Am Chem Soc (2004) 1.05
A novel function of plasminogen activator inhibitor-1 in modulation of the AKT pathway in wild-type and plasminogen activator inhibitor-1-deficient endothelial cells. J Biol Chem (2006) 1.05
Thrombospondin 1--a regulator of adenoma growth and carcinoma progression in the APC(Min/+) mouse model. Carcinogenesis (2003) 1.04
Plasminogen inhibits TNFalpha-induced apoptosis in monocytes. Blood (2006) 1.04
Oligomeric beta-structure of the membrane-bound HIV-1 fusion peptide formed from soluble monomers. Biophys J (2004) 1.04
Kinetic mechanism of enterococcal aminoglycoside phosphotransferase 2"-Ib. Biochemistry (2007) 1.02
Conservation of critical functional domains in murine plasminogen activator inhibitor-1. J Biol Chem (2004) 1.02
Blood component therapy in trauma guided with the utilization of the perfusionist and thromboelastography. J Extra Corpor Technol (2011) 1.02
Protein purification with polymeric affinity membranes containing functionalized poly(acid) brushes. Biomacromolecules (2010) 1.02
Bacterial plasminogen receptors utilize host plasminogen system for effective invasion and dissemination. J Biomed Biotechnol (2012) 1.01
Generation of genetically-altered mice producing very low levels of coagulation factorVII. Thromb Haemost (2005) 1.00
The crystal structures of the calcium-bound con-G and con-T[K7gamma] dimeric peptides demonstrate a metal-dependent helix-forming motif. J Am Chem Soc (2007) 0.99
Oligosaccharide binding in Escherichia coli glycogen synthase. Biochemistry (2009) 0.97
Fibrinogen stabilizes placental-maternal attachment during embryonic development in the mouse. Am J Pathol (2002) 0.96
Characterization of streptokinases from group A Streptococci reveals a strong functional relationship that supports the coinheritance of plasminogen-binding M protein and cluster 2b streptokinase. J Biol Chem (2012) 0.96
Unexpected role of anticoagulant protein C in controlling epithelial barrier integrity and intestinal inflammation. Proc Natl Acad Sci U S A (2011) 0.96
Platelet dysfunction is an early marker for traumatic brain injury-induced coagulopathy. Neurocrit Care (2013) 0.96
A natural inactivating mutation in the CovS component of the CovRS regulatory operon in a pattern D Streptococcal pyogenes strain influences virulence-associated genes. J Biol Chem (2013) 0.95
Binding of the gene repressor BlaI to the bla operon in methicillin-resistant Staphylococcus aureus. Biochemistry (2010) 0.95
TCR scanning of peptide/MHC through complementary matching of receptor and ligand molecular flexibility. J Immunol (2014) 0.94
Subtype-selective antagonism of N-methyl-D-aspartate receptor ion channels by synthetic conantokin peptides. Neuropharmacology (2007) 0.94
Fas/CD95 deficiency in ApcMin/+ mice increases intestinal tumor burden. PLoS One (2010) 0.93
The fibrinolytic system in dissemination and matrix protein deposition during a mycobacterium infection. Am J Pathol (2003) 0.93
A single amino acid replacement results in the Ca2+-induced self-assembly of a helical conantokin-based peptide. Biochemistry (2004) 0.93
The structure of Apo-wild-type cellular retinoic acid binding protein II at 1.4 A and its relationship to ligand binding and nuclear translocation. J Mol Biol (2006) 0.93
The crystal structure and mechanism of 1-L-myo-inositol- 1-phosphate synthase. J Biol Chem (2002) 0.92
The unorthodox SNAP50 zinc finger domain contributes to cooperative promoter recognition by human SNAPC. J Biol Chem (2006) 0.90
The X-ray crystallographic structure of the angiogenesis inhibitor angiostatin. J Mol Biol (2002) 0.90
Aminoglycoside 2''-phosphotransferase type IIIa from Enterococcus. J Biol Chem (2008) 0.90
Plasminogen enhances neuritogenesis on laminin-1. J Neurosci (2009) 0.90
Profibrinolytic effects of metalloproteinases during skin wound healing in the absence of plasminogen. J Invest Dermatol (2008) 0.90
A new mechanism for metal ion-assisted interchain helix assembly in a naturally occurring peptide mediated by optimally spaced gamma-carboxyglutamic acid residues. J Mol Biol (2004) 0.90
AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous hemorrhage. Blood (2011) 0.89
Helix-helix interactions between homo- and heterodimeric gamma-carboxyglutamate-containing conantokin peptides and their derivatives. J Biol Chem (2007) 0.89
Lack of plasminogen leads to milk stasis and premature mammary gland involution during lactation. Dev Biol (2006) 0.89
Conantokins and variants derived from cone snail venom inhibit naloxone-induced withdrawal jumping in morphine-dependent mice. Neurosci Lett (2006) 0.88
Genetic perturbation of glycolysis results in inhibition of de novo inositol biosynthesis. J Biol Chem (2005) 0.88
The structure of the 1L-myo-inositol-1-phosphate synthase-NAD+-2-deoxy-D-glucitol 6-(E)-vinylhomophosphonate complex demands a revision of the enzyme mechanism. J Biol Chem (2003) 0.88
Coagulation factor Xa modulates airway remodeling in a murine model of asthma. Am J Respir Crit Care Med (2006) 0.88
Sulindac treatment alters collagen and matrilysin expression in adenomas of ApcMin/+ mice. Carcinogenesis (2008) 0.88
Gene targeting of components of the fibrinolytic system. Thromb Haemost (2002) 0.87
alpha Domain deletion converts streptokinase into a fibrin-dependent plasminogen activator through mechanisms akin to staphylokinase and tissue plasminogen activator. J Biol Chem (2004) 0.87
Engineering a rhodopsin protein mimic. J Am Chem Soc (2006) 0.87
Early platelet dysfunction in a rodent model of blunt traumatic brain injury reflects the acute traumatic coagulopathy found in humans. J Neurotrauma (2013) 0.87
Critical role for conversion of glu-plasminogen to Lys-plasminogen for optimal stimulation of plasminogen activation on cell surfaces. Trends Cardiovasc Med (2003) 0.87
Functional dissection of Streptococcus pyogenes M5 protein: the hypervariable region is essential for virulence. PLoS One (2009) 0.86
Structure-function analysis of the streptokinase amino terminus (residues 1-59). J Biol Chem (2003) 0.86
An all-aqueous route to polymer brush-modified membranes with remarkable permeabilites and protein capture rates. J Memb Sci (2012) 0.86
N-methyl-D-aspartate receptor inhibition by an apolipoprotein E-derived peptide relies on low-density lipoprotein receptor-associated protein. Neuropharmacology (2008) 0.86
Complement-mediated opsonization of invasive group A Streptococcus pyogenes strain AP53 is regulated by the bacterial two-component cluster of virulence responder/sensor (CovRS) system. J Biol Chem (2013) 0.86
NR2B-selective conantokin peptide inhibitors of the NMDA receptor display enhanced antinociceptive properties compared to non-selective conantokins. Neuropeptides (2008) 0.85
X-ray crystallographic structure of the angiogenesis inhibitor, angiostatin, bound to a peptide from the group A streptococcal surface protein PAM. Biochemistry (2006) 0.85